Evidence map›Paper›PMID 27256065›Full record

ArticleBMC neurology2016

A case report of SPG11 mutations in a Chinese ARHSP-TCC family.

Linwei Zhang, Karen N McFarland, Jinsong Jiao, Yujuan Jiao

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC neurology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Research on clinical and molecular genetics of hereditary spastic paraplegia 11 patients in China.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2022
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Linwei ZhangDepartment of Neurology, China-Japan Friendship Hospital, 2 Yinghua Dongjie, Hepingli, 100029, Beijing, China.
Karen N McFarlandMcKnight Brain Institute and the Department of Neurology, College of Medicine, University of Florida, Gainesville, FL, 32610, United States of America.
Jinsong JiaoDepartment of Neurology, China-Japan Friendship Hospital, 2 Yinghua Dongjie, Hepingli, 100029, Beijing, China.
Yujuan JiaoDepartment of Neurology, China-Japan Friendship Hospital, 2 Yinghua Dongjie, Hepingli, 100029, Beijing, China. jiao.yujuan@hotmail.com.
China-Japan Friendship Hospital · CNUniversity of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutosomal recessive hereditary spastic paraplegia (ARHSP) with thin corpus callosum (TCC) is a complicated form of hereditary spastic paraplegia, characterized by progressive spastic paraplegia, weakness of the lower extremities and is usually accompanied by mental retardation. Mutations in the Spastic Paraplegia gene 11 (SPG11) account for a large proportion of ARHSP-TCC cases worldwide. CASE PRESENTATION: We describe a Chinese family with ARHSP-TCC. Two daughters of this family presented with a spastic gait and cognitive impairment. Brain imaging of the index patient revealed a thin corpus callosum. We performed detailed physical and auxiliary examinations and were able to exclude acquired causes of spastic paraplegia. To determine the causative mutation, we took a candidate gene approach and screened the coding sequence and some flanking intronic sequence of SPG11 by direct Sanger sequencing. We identified two novel compound heterozygous mutations in SPG11 in affected individuals (c.1551_1552delTT, p.Cys518SerfsTer39 and c.5867-1G > T (IVS30-1G > T), p.Thr1956ArgfsTer15). Bioinformatic analysis predicts that these mutations would lead to a loss of protein function due to the truncation of the SPG11 protein.

conclusionsThe results of this case report indicate a broader approach to include screening for SPG11 mutations in ARHSP-TCC patients. Our findings enrich the phenotypic spectrum of SPG11 mutations.

Indexed as

MutationAdultAsian PeopleCorpus CallosumDNA Mutational AnalysisFemaleHumansMalePedigreeProteinsSpastic Paraplegia, HereditaryProteinsSPG11 protein, humanAutosomal recessive hereditary spastic paraplegia with thin corpus callosum (ARHSP-TCC)Gene mutationHeterozygous mutationsSPG11

Identifiers

PMID27256065
PMCPMC4891852
OpenAlexW2416967738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.